Research Appraisals
Evidence-based critical appraisals of the latest medical research, systematically evaluated using Oxford CEBM methodology.
Showing 11 appraisals
Journal of the American Heart Association
Diagnostic and Prognostic Utility of Mitral Annular Plane Systolic Excursion: A Systematic Review and Meta-Analysis
BACKGROUND: Movement of the mitral annulus toward the left ventricular (LV) apex during systole, termed atrioventricular plane displacement or mitral annular plane systolic excursion (MAPSE), was first observed by Leonardo da Vinci in the 15th century. MAPSE, a measure of longitudinal movement, shows good agreement between transthoracic echocardiography and cardiovascular magnetic resonance imaging and can also be measured by transesophageal echocardiography and cardiac computed tomography. Measurement is fast, simple, and easily automated. However, no major imaging guidelines advise routine measurement. METHODS: We present a systematic review of studies appraising the diagnostic and prognostic performance of MAPSE from PubMed, Medline, Google Scholar, and Embase until September 2025 in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Studies assessing MAPSE in adult populations were included, and non-English publications, abstracts, and studies of congenital heart disease were excluded. Newcastle-Ottawa Scale assessed study quality. Correlation coefficients between MAPSE and markers of systolic function were pooled using Hunter-Schmidt meta-analysis. Heterogeneous diagnostic and prognostic outcomes were synthesized narratively. RESULTS: The review included 92 studies. MAPSE correlated with LV ejection fraction (r=0.64 [95% CI, 0.54-0.74]) and global longitudinal strain (r=0.53 [95% CI, 0.45-0.63]), showing a modest association with systolic function, particularly useful in patients with poor echocardiographic windows. MAPSE was frequently reduced despite preserved LV ejection fraction across multiple pathologies, enabling earlier detection of systolic impairment. MAPSE also demonstrated strong prognostic value, outperforming LVEF and global longitudinal strain in predicting adverse events in several studies. CONCLUSIONS: Overall, MAPSE has a clinically important role meriting integration into routine cardiac imaging and care.
9 July 2026
Read appraisal →The American journal of cardiology
Transcatheter Chordal Repair for Degenerative Mitral Regurgitation: Systematic Review and Meta-analysis
Transcatheter chordal repair enables off-pump, echocardiography-guided treatment of degenerative mitral regurgitation, but real-world outcomes remain variably reported. We performed a systematic review and meta-analysis of studies evaluating outcomes after transcatheter chordal repair in adults with primary degenerative mitral regurgitation. Pooled event rates were calculated using random-effects models. Seventeen studies (n = 3,787) were included. Mitral regurgitation ≤ mild was achieved in 93.9% of patients at discharge and 82.5% at 30 days, while moderate mitral regurgitation occurred in 5.0% and 17.5%, respectively. Procedural success was 96.2%, although small-study effects were suggested. Early adverse events were infrequent, with 30-day mortality of 1.2%, stroke of 0.7%, and myocardial infarction of 1.2%. Reintervention occurred in 4.5%. In conclusion, transcatheter chordal repair demonstrates high technical success and favorable early safety; however, early mitral regurgitation recurrence and heterogeneity highlight the need for anatomy-guided patient selection and cautious interpretation given single-arm study limitations.
15 June 2026
Read appraisal →Heart (British Cardiac Society)
Natural history of asymptomatic moderate or severe aortic regurgitation: a systematic review and meta-analysis
BACKGROUND: The natural history of asymptomatic moderate or severe aortic regurgitation (AR) remains uncertain, with conflicting reports about its progression and surgical timing. We aimed to quantify adverse outcomes under conservative management and evaluate the association of aortic valve replacement/repair (AVR) with mortality. METHODS: Systematic searches (inception-July 2025) identified cohort studies of asymptomatic moderate/severe AR. Random-effects models estimated pooled incidence rates of adverse events; fixed-effects models were used for hazard ratios (HRs) of AVR vs conservative management. RESULTS: Twenty-seven studies (4720 patients; mean age 49 years; mean follow-up 3.9 years) were included. Pooled incidence rates per 100 person-years were 1.75 (95% CI 1.27 to 2.41) for all-cause mortality, 1.29 for cardiac death, 0.29 for sudden death, 4.30 for new symptoms and 7.01 for AVR. Asymptomatic low left ventricular ejection fraction occurred in only 0.9 per 100 person-years. Mortality rates were more than double those of the general population across age groups-2.45 (1.90 to 3.18) per 100 person-years for cohorts with mean age ≥50 years versus 0.59 (0.29 to 1.21) for younger cohorts. Early AVR was associated with lower mortality (pooled HR 0.33; 95% CI 0.30 to 0.37). CONCLUSION: Asymptomatic moderate/severe AR carries significant excess mortality irrespective of age, contradicting its historically benign reputation. Given the rarity of asymptomatic LV dysfunction, earlier intervention guided by more sensitive markers of LV damage may improve outcomes, although heterogeneity and study quality warrant cautious interpretation. PROSPERO REGISTRATION NUMBER: CRD42024522683.
27 May 2026
Read appraisal →Journal of medical Internet research
Alignment Between Cardiologists and AI-Driven Diagnostic Systems: Mixed Methods Study
BACKGROUND: The clinical value of artificial intelligence (AI)-based diagnostic systems depends not only on their accuracy but also on how well their outputs integrate with clinicians' judgments in practice. Critical knowledge gaps remain regarding diagnostic concordance between AI and clinicians in stress echocardiography interpretation, patient characteristics predicting discordance, and how cardiologists respond when AI recommendations conflict with their clinical diagnoses. OBJECTIVE: This study examined the diagnostic alignment between an AI-driven stress echocardiography system (EchoGo Pro [EGP]) and cardiologists' diagnoses of coronary artery disease (CAD), identified predictors of concordance and AI scan rejection, and explored cardiologists' decision-making strategies when disagreements arise. METHODS: We conducted mixed methods research. The quantitative study analyzed concordance between EGP and cardiologists using data from 854 participants with suspected CAD in the multicenter PROTEUS randomized controlled trial. Logistic regression identified predictors of agreement, disagreement, and scan rejection, adjusting for age, sex, smoking status, BMI, and cardiovascular risk factors (hypertension, hypercholesterolemia, diabetes, family history of CAD, and prior CAD events). To gain deeper insight into discordance, we conducted a qualitative study analyzing survey responses from 61 UK consultant cardiologists recruited via Qualtrics, exploring their perceptions of AI tools, the risks of following discordant AI recommendations, and their typical responses to AI-clinician disagreement. RESULTS: EGP and cardiologists agreed in 60% (512/854) of the cases, but agreement was significantly lower among patients with hypertension (OR 0.58, 95% CI 0.38-0.89; P=.01), diabetes (OR 0.56, 95% CI 0.35-0.90; P=.02), and pre-existing CAD (OR 0.48, 95% CI 0.30-0.77; P=.002). EGP rejected 26.1% (222/854) of the scans due to insufficient image quality, with rejection significantly more common in male patients (β=0.35; P=.03) and those with a family history of CAD. If a positive CAD diagnosis was assigned when either cardiologists or EGP identified CAD, the proportion of positive cases increased from 17.9% (153/854) to 22.1% (189/854), potentially identifying additional at-risk patients. Survey respondents (50/60, 85% male; 26/57, 46% aged 40-49 years; 39/61, 64% White) required 65% to 69% confidence in their initial diagnosis to justify disregarding contradictory AI recommendations. The survey findings revealed cardiologists treated AI recommendations as advisory rather than definitive. When facing discordance, they retained confidence in their judgment and sought corroboration through additional testing, data review, or second opinions rather than deferring to AI. Paradoxically, cardiologists with higher confidence in AI tools required greater confidence in their own diagnosis to disregard AI recommendations (β=7.73; P=.02). Cardiologists attributed discordance primarily to AI's inability to incorporate patient history, comorbidities, and broader clinical context. CONCLUSIONS: EGP shows promise as an adjunctive tool but struggles with multimorbid patients and exhibits high, uneven rejection rates. Cardiologists use AI to prompt scrutiny, not replace judgment. Future systems need to integrate wider patient data with imaging and minimize bias through representative training to avoid exacerbating inequities.
21 May 2026
Read appraisal →European heart journal
Digital profile of children's hearts: automated echocardiogram strain analysis facilitates earlier detection of cardiac dysfunction
BACKGROUND AND AIMS: Paediatric myocardial strain analysis through echocardiography is often characterized by high variance and limited precision, highlighting the need for a standardized and vendor-agnostic approach applicable for diverse image qualities and populations, which could enhance cardiac function evaluation and enable early detection of cardiac impairment. METHODS: The Motion-Echo system was proposed, a semi-supervised deep learning framework built on 11 096 paediatric and 11 297 adult echocardiograms spanning diverse image qualities and vendors. It integrated context compensation and motion estimation modules for temporally coherent segmentation, myocardial motion estimation, and global strain assessment with minimal manual annotations. Clinical utility was further evaluated through downstream applications. RESULTS: Motion-Echo achieved mean absolute errors of 2.099% [95% confidence interval (CI) 1.803-2.401] and 2.665% (95% CI 2.339-3.026) for global longitudinal and circumferential strain assessments, with Pearson correlation coefficients of 0.799 (95% CI 0.715-0.871) and 0.781 (95% CI 0.687-0.844), respectively. To validate the clinical utility, automated strain values achieved an area under the curve (AUC) of 0.906 (95% CI 0.816-0.981) for cancer therapy-related cardiac dysfunction risk prediction. For late gadolinium enhancement detection, automated global longitudinal strain reached an AUC of 0.782 (95% CI 0.666-0.885). For left ventricular ejection fraction decline forecasting, the system outperformed manual strain values (DeLong P < .001). In addition, incorporating estimated motion flows yielded a remarkable AUC improvement to 0.952 (95% CI 0.917-0.980) for myocardial infarction detection. CONCLUSIONS: Leveraging a large-scale paediatric dataset, Motion-Echo provided a reliable and generalizable framework for myocardial strain analysis, demonstrating potential to facilitate earlier detection of cardiac dysfunction and generate digital cardiac function profiles of children.
16 May 2026
Read appraisal →JACC. Cardiovascular interventions
Durability of Mitral Valve Transcatheter Edge-to-Edge Repair: An Expert Overview
BACKGROUND: Mitral regurgitation (MR) is a globally endemic heart disease burden with significant morbidity and mortality. Mitral transcatheter edge-to-edge repair (M-TEER) has emerged as a minimally invasive treatment with established safety and intermediate-term efficacy. OBJECTIVES: The aim of this study was to determine M-TEER durability and the incidence, risk factors, and treatment strategies of M-TEER failure. METHODS: A comprehensive literature review was performed, identifying 457 records, from which 33 full-text papers were included. Definitions of MR recurrence, reintervention, and M-TEER durability and failure were provided. On the basis of these definitions, weighted means with 95% CIs were calculated for the rates of MR recurrence, reintervention, and their composite for both the overall population and the primary and secondary MR subgroups. RESULTS: The pooled weighted means of MR recurrence and reintervention ranged between 5% and 10% in the first months after the index procedure, remained relatively stable for the first 3 years, and increased at 5 years to 17% and 9%, respectively. MR recurrence and reintervention weighted means were numerically higher in primary than secondary MR, and 41% of primary MR patients experienced MR recurrence or reintervention at 5 years. Redo transcatheter edge-to-edge repair for M-TEER failure seemed safer than surgery but was associated with 1-year MR recurrence rates between 20% and 40%. Mitral valve replacement was the most common surgical technique for M-TEER failure. CONCLUSIONS: The incidence of M-TEER failure after a successful index procedure increases after 3 years and is more pronounced with primary than secondary MR. More systematic, longer term follow-up data after M-TEER are required to better define M-TEER durability.
14 May 2026
Read appraisal →European heart journal
Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial
BACKGROUND AND AIMS: The TRISCEND II trial demonstrated superior clinical benefits for patients with ≥severe tricuspid regurgitation (TR) treated with the EVOQUE transcatheter tricuspid valve replacement (TTVR) system plus medical therapy vs medical therapy alone. This work reports 1-year and 18-month outcomes in patients stratified by baseline TR severity. METHODS: The multicentre, prospective TRISCEND II trial enrolled 400 patients with symptomatic, ≥severe TR, and randomized 2:1 to TTVR (n = 267) or control (n = 133). In a post hoc analysis, patients were stratified into severe TR (n = 172) and massive/torrential TR (n = 220) cohorts. Clinical and quality-of-life outcomes were reported at 1 year, with Kaplan-Meier estimates for all-cause mortality and heart failure (HF) hospitalization assessed at 18 months. Study oversight included an independent echocardiographic core laboratory, clinical events committee, and data safety monitoring board. RESULTS: One year after TTVR, TR was ≤mild in 95.2% of severe TR and 95.3% of massive/torrential TR patients. The primary safety and effectiveness endpoint (win ratio) favoured TTVR over control regardless of baseline TR severity: severe {1.64 [95% confidence interval (CI): 1.11, 2.43]} and massive/torrential [2.20 (1.55, 3.14)]. At 18 months, TTVR patients had similar mortality to controls [rate difference: severe 0.2% (-11.6, 11.9), massive/torrential -5.8% (-17.6, 6.0)], whereas HF hospitalization rates favoured TTVR in the massive/torrential cohort [vs control, severe 9.8% (-3.0, 22.7), massive/torrential -15.2% (-28.9, -1.5)]. CONCLUSIONS: Patients with ≥severe TR benefit from TTVR, experiencing improvements in TR severity, functional capacity, and quality of life regardless of baseline TR severity, with a signal for greater benefit in patients with more advanced disease.
11 May 2026
Read appraisal →Open heart
Relative apical sparing of left ventricular longitudinal strain for the diagnosis of cardiac amyloidosis: a systematic review and meta-analysis
BACKGROUND: Cardiac amyloidosis (CA) is underdiagnosed due to non-specific clinical and echocardiographic features. This systematic review and meta-analysis evaluated the diagnostic accuracy of the left ventricular relative apical sparing (RELAPS) pattern on speckle-tracking echocardiography. METHODS: A literature search of PubMed, Scopus and Cochrane was conducted through August 2025. RELAPS was defined as the average apical longitudinal strain divided by the sum of average basal and average middle left ventricular longitudinal strains. Diagnostic accuracy was assessed using a bivariate random-effects model. Subgroup analyses by CA subtype and echocardiogram software, and meta-regression for clinical variables, were performed. Optimal cut-offs were determined by maximising the Youden index. Analyses were conducted in R V.4.4.1. RESULTS: Forty-one studies (3473 CA; 4525 comparators) were included. Pooled analysis yielded an area under the receiver operating characteristic curve (AUC-ROC) of 0.818, with sensitivity 65.9% (95% CIs 59.2% to 72.0%) and specificity 83.1% (CI 78.5% to 86.8%). The diagnostic oods ratio (DOR) was 9.54 (CI 7.41 to 12.10). In subtype analyses, immunoglobulin light chains (AL-CA) showed AUC-ROC 0.876, sensitivity 59.8% (CI 41.1% to 76.0%) and specificity 92.7% (CI 83.6% to 96.9%); transthyretin (ATTR-CA) showed AUC-ROC 0.822, sensitivity 63.8% (CI 51.2% to 74.8%) and specificity 84.4% (CI 76.7% to 89.9%), with no significant differences between subtypes (sensitivity p=0.760; specificity p=0.172). Three echocardiography software systems were evaluated. GE EchoPAC (26 studies) achieved an AUC-ROC of 0.822 (sensitivity 70.4% (CI 64.1% to 76.0%), specificity 81.2% (CI 75.7% to 85.7%)). Philips QLAB (four studies) performed comparably (AUC-ROC 0.904; sensitivity 67.6% (CI 31.2% to 90.6%), specificity 92.7% (CI 73.6% to 98.3%)). In contrast, TomTec (four studies) had an AUC-ROC of 0.806, but its sensitivity (31.1% (CI 9.4% to 66.3%)) was significantly lower than GE EchoPAC's (p<0.001), despite a similar specificity (93.6% (CI 78.8% to 98.3%)). CONCLUSION: RELAPS provides moderate diagnostic accuracy for identifying CA, with good specificity and modest sensitivity. Performance varies by analysis software and threshold, underscoring the need for standardised measurement and prespecified cut-offs.
27 Apr 2026
Read appraisal →European journal of preventive cardiology
A comprehensive analysis of the impact of high-intensity interval vs. moderate-intensity continuous training on global and regional myocardial function in patients early after acute myocardial infarction: the STRAICT randomized controlled trial
AIMS: This study aims to compare the effect of moderate-intensity continuous training (MICT) vs. isovolumic high-intensity interval training (HIIT) on left ventricular (LV) myocardial function early post-acute myocardial infarction (AMI). Training-induced changes were analysed at both global and segmental levels using advanced deformation echocardiographic imaging techniques. METHODS AND RESULTS: One hundred AMI patients were randomly assigned to participate in an 8-week training programme comprising either MICT (n = 50) or isovolumic HIIT (n = 50), starting within 6 weeks post-AMI. Before and after cardiac rehabilitation (CR), we carried out a comprehensive and detailed evaluation of myocardial function, including measurements of LV longitudinal strain (LS) and circumferential strain and torsional mechanics, LV myocardial work (MW) and mechanical dispersion [post-systolic shortenings (PSS)] indexes, and atrial strains. Mixed models were used to evaluate the effect of MICT and HIIT on speckle-tracking echocardiography parameter. Both MICT and HIIT resulted in a similar improvement in the amplitude and timing of LV LS (time effect P < 0.001 in each case), as depicted by the comparable increase in global LS [HIIT: -0.82%, 95% confidence interval (CI): -0.19/-61; MICT: -1.11%, 95% CI: -1.17/-0.51; time ∗ group P = 0.71], MW index and efficiency, constructive MW, and reduction in the number of PSS and wasted MW (time ∗ group P > 0.12 in each case) in the two groups. These improvements were observed in all myocardial territories, regardless of previous ischaemic risk status (culprit vessel-by-time-by-group interactions, P > 0.60 in each case). Circumferential strains remained unchanged in both groups while there was a trend (time ∗ group P = 0.04) for LV torsion to decrease for MICT (P = 0.06) and increase for HIIT (P = 0.36) after CR. Left atrial strains during the reservoir and conduit phases improved (time effect P < 0.05) similarly in MICT vs. HIIT (time ∗ group P > 0.54). V̇O2peak (P < 0.001) and quality of life (P < 0.001) improved equally in MICT and HIIT after CR. CONCLUSION: Early supervised exercise-based CR, whether using MICT or isovolumic HIIT, improves longitudinal myocardial function in both culprit and non-culprit territories after AMI. Exercise-based cardiac rehabilitation (CR) is an effective strategy for reducing cardiovascular morbidity and mortality in patients after a myocardial infarction (MI). While moderate-intensity continuous training (MICT) has been the traditional form of aerobic exercise in CR, high-intensity interval training (HIIT) is gaining popularity due to its demonstrated feasibility, safety, and potential superiority in improving physical fitness. The impact of CR on heart function after MI is not well understood. It is still unclear whether HIIT is more effective than MICT for improving heart function. This uncertainty is due to limitations in previous studies, such as differences in total workload realized, which is an important factor in CR. It is also unclear whether different types of exercise training have different effects on parts of the heart that were damaged due to reduced blood flow during the heart attack compared with the areas that were not affected. This study aims to fill these gaps by comparing HIIT and equal-volume MICT using advanced echocardiographic imaging techniques to evaluate overall and regional heart function, focusing on both affected and unaffected areas of the heart. We found thatExercise-based CR initiated early after the heart attack effectively improves cardiac function, with HIIT as effective as isovolumic MICT.These improvements were observed equally with both MICT and HIIT across all areas of the heart, confirming its ability to functionally recover even in regions previously impacted by reduced blood flow.
24 Apr 2026
Read appraisal →Journal of the American Heart Association
Left Atrial Volume Index and Left Ventricular Mass Index Determine the Benefits of Spironolactone in Patients With Heart Failure With Preserved Ejection Fraction
BACKGROUND: It is unclear whether patients with heart failure with preserved ejection fraction respond to spironolactone based on cardiac structure or function. METHODS: A post hoc analysis was performed among participants with left ventricular (LV) ejection fraction ≥50% and evidence of abnormal LV diastolic function or filling pressures in TOPCAT (Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial). Log-rank tests and Cox regression models were used for comparison between groups. RESULTS: Totally, 757 subjects were qualified and stratified by parameters on cardiac structure or function. In patients with increased left atrial volume index, spironolactone reduced cardiovascular mortality (adjusted hazard ratio [HR], 0.48 [95% CI, 0.24-0.98]; P=0.042, log-rank; interaction P=0.045). Meanwhile, in patients with increased LV mass index, spironolactone decreased heart failure hospitalization (adjusted HR, 0.51 [95% CI, 0.32-0.80]; P=0.009, log-rank; interaction P=0.041) and the composite outcome of cardiovascular mortality, heart failure hospitalization, and aborted sudden death (adjusted HR, 0.63 [95% CI, 0.43-0.93]; P=0.045, log-rank; interaction P=0.029). Then, in participants with increased left atrial volume index and LV mass index, who matched at 1:1 ration by propensity score matching, spironolactone reduced cardiovascular mortality (adjusted HR, 0.31 [95% CI, 0.11-0.92]; P=0.039, log-rank), heart failure hospitalization (adjusted HR, 0.26 [95% CI, 0.10-0.68]; P=0.005, log-rank), and the composite outcome (adjusted HR, 0.33 [95% CI, 0.15-0.72]; P=0.006, log-rank). CONCLUSIONS: Spironolactone reduced cardiovascular mortality, heart failure hospitalization, or the composite outcome of cardiovascular mortality, heart failure hospitalization, and aborted sudden death in patients with heart failure with preserved ejection fraction with increased left atrial volume index or LV mass index.
8 Apr 2026
Read appraisal →J Am Coll Cardiol
Contemporary Diagnosis and Treatment of Aortic Regurgitation: A State-of-the-Art Review
Aortic regurgitation (AR) is progressive and frequently under-recognized; without timely intervention it drives adverse left-ventricular remodeling and heart failure. Despite Class I guideline indications, many patients-especially older, frail individuals with multimorbidity-remain untreated. Advancements in high-fidelity multimodality imaging-including cardiac magnetic resonance, 4-dimensional flow, and speckle-tracking echocardiography-have enabled earlier detection of remodeling and more accurate quantification of regurgitant burden. These techniques are redefining thresholds for treatment and may enable biomarker-imaging composite staging of disease. Surgery remains the gold standard of therapy for native AR. Contemporary surgical management is tailored to age, anatomy, and root pathology. Although surgical aortic valve replacement remains the predominant therapy for most candidates, valve-sparing root procedures, the Ross operation, and aortic valve neocuspidization are increasingly offered at experienced centers for carefully selected lower-risk patients. Transcatheter aortic valve replacement is expanding rapidly as a viable option that helps bridge the treatment gap for those at prohibitive or high risk for surgery. Yet, devices optimized for calcific aortic stenosis encounter technical obstacles in native AR-including large, noncalcified annuli, elliptical root geometry, and high stroke volumes-leading to suboptimal anchoring, residual paravalvular regurgitation, and device embolization. Purpose-built AR systems with leaflet-engaging anchoring and enhanced sealing have shown encouraging outcomes in feasibility and pivotal studies and have obtained commercial approval in Europe, and U.S. authorization is anticipated. This state-of-the-art review synthesizes current insights into AR pathophysiology, diagnostic advances, and therapeutic innovations in surgical and transcatheter techniques, highlighting knowledge gaps and proposing research priorities to accelerate access to care for this historically undertreated population.
1 Feb 2026
Read appraisal →